title: Converting enzyme inhibition normalizes QT interval in spontaneously hypertensive rats.
abstract: We quantified the repolarization time (so-called QT interval) in a rat, an animal species that does not show a well-characterized T wave on surface ECG. We used spontaneously hypertensive rats (SHR) and converting enzyme inhibition to demonstrate a reversible increase in QT interval in pressure-overloaded hearts in the absence of ischemia. An implanted telemetry system recording ECG data in freely moving rats was used to automatically calculate the RR interval. The QT duration was manually determined by use of a calibrated gauge, and a time-frequency domain analysis was used to evaluate heart rate variability. Left ventricular mass was sequentially assessed by echocardiography. Before treatment, 12-month-old SHR had higher left ventricular mass, QT and RR intervals, and unchanged heart rate variability compared with age-matched Wistar rats. A 2-month converting enzyme inhibition treatment with trandolapril reduces systolic blood pressure, left ventricular mass, and QT interval. The RR interval and heart rate variability remains unchanged. There is a positive correlation between the QT interval and left ventricular mass. The SHR is suitable for longitudinal studies on the QT interval. Thus, the detection of the QT interval reflects the phenotypic changes that occur during mechanical overload and, on the basis of these criteria, allows an in vivo determination of the adaptational process.
authors.affiliation: U127-INSERM, Hôpital Lariboisiere, Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Baillard
authors.forename: P
authors.initials: P
authors.lastname: Mansier
authors.forename: P V
authors.initials: PV
authors.lastname: Ennezat
authors.forename: L
authors.initials: L
authors.lastname: Mangin
authors.forename: C
authors.initials: C
authors.lastname: Medigue
authors.forename: B
authors.initials: B
authors.lastname: Swynghedauw
authors.forename: B
authors.initials: B
authors.lastname: Chevalier
mesh_terms: D000367:Age Factors; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D004195:Disease Models, Animal; D004452:Echocardiography; D004562:Electrocardiography / Q000187:drug effects*; D015716:Electrocardiography, Ambulatory / Q000379:methods*; D006339:Heart Rate / Q000187:drug effects*; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D017379:Hypertrophy, Left Ventricular / Q000503:physiopathology*; D007211:Indoles / Q000494:pharmacology; D015588:Observer Variation; D051381:Rats; D011918:Rats, Inbred SHR; D017208:Rats, Wistar; D012044:Regression Analysis; D015203:Reproducibility of Results; D013045:Species Specificity
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D007211:Indoles; C052035:trandolapril